Carisome™ Posters and Abstracts

Learn more about the promise of the Carisome™ platform from the data presented at recent meetings.

American Academy of Cancer Research (AACR)

Plasma exosome-based biosignatures: A novel method for early diagnosis of colorectal cancer
David Spetzler, Traci Pawlowski, Jeff Kimbrough, Ta Deng, Teresa Tinder, Joon Kim and Christine Kuslich

Plasma exosomes are a robust biosignature for prostate cancer
Christine Kuslich, Traci Pawlowski, Jeff Kimbrough, Ta Deng, Teresa Tinder, Joon Kim and David Spetzler

Important differences between exosome biosignatures from prostate cancer patient plasma samples and prostate cancer cell lines
Teresa Tinder, Traci Pawlowski, David Spetzler, Amber Conrad, Phil Ellis, Patrick Kennedy, Annemarie Tyrell, Unnati Jariwala and Christine Kuslich

Identification and characterization of exosome subpopulations to provide the foundation for a novel exosome-based cancer diagnostic platform
Traci Pawlowski, David Spetzler, Teresa Tinder, Paula Esmay, Amber Conrad, Phil Ellis, Patrick Kennedy, Annemarie Tyrell, Unnati Jariwala and Christine Kuslich

American Society of Clinical Oncology (ASCO)

A sensitive exosome-based biosignature for the diagnosis of prostate cancer
Christine Kuslich, Traci L. Pawlowski, Ta Deng, Teresa Tinder, Joon Kim, Jeff Kimbrough, David Spetzler Caris Life Sciences, Phoenix, AZ

Circulating exosomes may provide an alternate platform to monitor disease progression compared to circulating tumor cells
Traci Pawlowski, David Spetzler, Teresa Tinder, Jeff Kimbrough, Ta Deng, JoonKim, Philip Ellis, Annemarie Tyrell and Christine Kuslich